<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
  <head>
    <meta charset="utf-8" />
<link rel="canonical" href="https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-first-its-kind-donation-matching-program/" />
<meta property="og:site_name" content="Regeneron Pharmaceuticals Inc." />
<meta property="og:type" content="website" />
<meta property="og:url" content="https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-first-its-kind-donation-matching-program" />
<meta property="og:title" content="Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization | Regeneron Pharmaceuticals Inc." />
<meta property="og:description" content="Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medications TARRYTOWN, N.Y. , June 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the launch of a pioneering matching program for donations to Good" />
<meta property="og:image" content="https://regeneronpharmaceuticalsinc.gcs-web.com/static-files/b39477e0-886d-48f7-bba0-52cf365365ea" />
<meta property="og:image:url" content="https://regeneronpharmaceuticalsinc.gcs-web.com/static-files/6981e034-a9ba-4497-b36d-e8b03fc3d639" />
<meta name="twitter:image" content="https://regeneronpharmaceuticalsinc.gcs-web.com/static-files/b85ec1fa-e6b9-4599-939d-8b699200cf78" />
<meta name="Generator" content="Drupal 10 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<script type="application/ld+json">{
          "@context": "https://schema.org",
          "@type": "BreadcrumbList",
          "itemListElement": [{
              "@type": "ListItem",
              "position": "1",
              "name": "news releases"
            },{
              "@type": "ListItem",
              "position": "2",
              "name": "news release details"
            },{
            "@type": "ListItem",
            "position": "3",
            "name": "Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization",
            "item": "https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-first-its-kind-donation-matching-program"
          }]}</script>
<link rel="icon" href="/sites/g/files/knoqqb100256/files/favicons_0.png" type="image/png" />
<link rel="alternate" hreflang="en" href="https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-first-its-kind-donation-matching-program" />

    <title>Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization | Regeneron Pharmaceuticals Inc.</title>
    <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb100256/files/css/css_PsbcRtxDWgk50gEtPLE8YKVZ27gKo__6kTcC2w1TUT0.css?delta=0&amp;language=en&amp;theme=client_site_301&amp;include=eJyNjksOAjEMQy80oiAOFLmdaAjTpigJv9vTQWxYILGzn2zLpQprkEswHfeH1G9sdxvOp9KN02zXC-oOZzy-wCyofZlUjDKc0yakdPU3arCVg2YEKNde1gRFfXqQIUSX0TEqJ1j8FXcK5Mo_so2hZFx6a6yDS9fPto8Jbmk7-AIVUls4" />
<link rel="stylesheet" media="all" href="/sites/g/files/knoqqb100256/files/css/css_ewDgc_5j2JIJPWAvISVEe8DZi7gwX0T2zAC51kMfwyI.css?delta=1&amp;language=en&amp;theme=client_site_301&amp;include=eJyNjksOAjEMQy80oiAOFLmdaAjTpigJv9vTQWxYILGzn2zLpQprkEswHfeH1G9sdxvOp9KN02zXC-oOZzy-wCyofZlUjDKc0yakdPU3arCVg2YEKNde1gRFfXqQIUSX0TEqJ1j8FXcK5Mo_so2hZFx6a6yDS9fPto8Jbmk7-AIVUls4" />
<link rel="stylesheet" media="all" href="https://fonts.googleapis.com/css2?family=Roboto+Condensed:ital,wght@0,400;0,700;1,400;1,700&amp;amp;family=Roboto:ital,wght@0,400;0,500;0,700;1,400;1,500;1,700&amp;amp;family=Barlow+Condensed:wght@900&amp;amp;display=swap" />
<link rel="stylesheet" media="all" href="https://fonts.googleapis.com/css2?family=Barlow+Condensed:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&amp;display=swap" />
<link rel="stylesheet" media="all" href="/sites/g/files/knoqqb100256/files/css/css_IBI-YCeTgUmgUTDI2POLsBkVhcI4gupJvQbugFqHjYk.css?delta=4&amp;language=en&amp;theme=client_site_301&amp;include=eJyNjksOAjEMQy80oiAOFLmdaAjTpigJv9vTQWxYILGzn2zLpQprkEswHfeH1G9sdxvOp9KN02zXC-oOZzy-wCyofZlUjDKc0yakdPU3arCVg2YEKNde1gRFfXqQIUSX0TEqJ1j8FXcK5Mo_so2hZFx6a6yDS9fPto8Jbmk7-AIVUls4" />

    <script src="/core/assets/vendor/modernizr/modernizr.min.js?v=3.11.7"></script>
<script src="/sites/g/files/knoqqb100256/files/js/js_AERsBivS_4somOkPlP06Na3A7OX9CSNwYiN7SWmsrws.js?scope=header&amp;delta=1&amp;language=en&amp;theme=client_site_301&amp;include=eJyNj9EOwjAIRX_ItBo_iLBClMnahTKnf2_Tacx8MjxwL5yQS1Lh7FDFGc7HUyx3ttWaq4csBphRny6pxp0LSGVgUFxyuv4BzlaoY-nGJF4MCL3VoFzjV3ZkWtRlahjGve3bGS8cPyLgiA9AIkiKtQIqm29XVh76T7m0GLyl-pmFd38B1u1mog"></script>

    <!-- OneTrust Cookies Consent Notice start for investor.regeneron.com -->
    <script src=https://cdn.cookielaw.org/scripttemplates/otSDKStub.js  type="text/javascript" charset="UTF-8" data-domain-script="339677b1-8ff6-4431-a0fc-807f0ec0de38" ></script>
    <script type="text/javascript">
    function OptanonWrapper() { }
    </script>
    <!-- OneTrust Cookies Consent Notice end for investor.regeneron.com -->

<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-N94H6NR3');</script>
<!-- End Google Tag Manager -->



  </head>
  <body class="nir-node nir-node--type-nir-news nir-node--31106 reborn_lite path-node page-node-type-nir-news">
    <div id="skip">
      <a class="visually-hidden focusable skip-link" href="#main-menu">
        Skip to main navigation
      </a>
    </div>
    
      <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    


<a href="#lfg-content" class="btn btn-primary btn-skip-to-content" tabindex="0">
    <div class="btn-content">
        <span>Skip to Content</span>
    </div>
</a>
<header>
    <div class="header-nav">
        <div class="container header-nav-container">
            <div class="row d-none d-lg-block p-0">

                <div class="container">
                    <div class="row row-utility-links">

                        <a class="logoLink imgLink d-none d-md-inline d-lg-inline flex-fill" href="/" aria-label="Regeneron Pharmaceuticals Inc. " title="Regeneron Pharmaceuticals Inc.">
                            <img src="/sites/g/files/knoqqb100256/themes/site/client_site_301/local/images/logo/logo-regeneron-blue.svg" width="223" height="24" alt="Regeneron Pharmaceuticals Inc. Logo." />
                        </a>

                                                <div class="utility-links" role="navigation" aria-label="utility nav">
                            
    

              
              
                

    
    

                    
              
                  

        


          <a href="https://regeneron.com/" rel="nofollow noreferrer"  class="utility-link" target="_blank"   class="utility-link"  aria-label="Regeneron.com">Regeneron.com</a>

          

              

        


          <a href="https://www.regeneron.com/contact" rel="nofollow noreferrer"  class="utility-link contact-link"   target="_blank"   class="utility-link contact-link"  aria-label="Contact Us">Contact Us</a>

          

              


  


    
    
                        </div>
                        
                        <div class="searchGlobal">
                            <div class="navbar-search">
                                <form class="d-flex" role="search" action="/search" method="get" id="views-exposed-form-search-page-1" >
                                    <input class="form-control form-text"  data-drupal-selector="edit-query" type="text" id="edit-query" name="query"type="search" aria-label="Search text" required tabindex="-1">

                                    <button class="btn" type="submit" tabindex="-1"><span>Search</span></button>
                                </form>
                            </div>

                            <button class="btn navbar-search-toggle" type="button" aria-label="Open Search Bar"
                                    aria-expanded="false"><span>Open Search Bar</span></button>

                        </div><!-- END searchGlobal -->
                    </div>
                </div>

            </div>

            <div class="row nav-main-row">
                <div class="col-12">
                    <nav aria-label="main">
                        <div class="container">
                            <div class="nav-main">
                                <a class="logoLink imgLink d-lg-none" href="/" aria-label="Regeneron Pharmaceuticals Inc." title="Regeneron Pharmaceuticals Inc.">
                                    <img src="/sites/g/files/knoqqb100256/themes/site/client_site_301/local/images/logo/logo-regeneron-blue.svg" width="223" height="24"
                                         alt="Regeneron Pharmaceuticals Inc. logo" />
                                </a>

                                                                    
    

              
              
                

    
    

                    
              
                                            
        


                                  <a href=""  aria-label="News"  class="nav-main-link" data-targetSubNav="nav-sub-1"    class="nav-main-link"   data-block-uuid="8abb77fe-5d11-4c0e-8136-5cc6dcf410f2" data-bs-toggle="dataToggle" aria-expanded="false">
            <span>News</span>
          </a>
        
          
                
                                        
        


                                  <a href=""  aria-label="Events &amp; Presentations"  class="nav-main-link" data-targetSubNav="nav-sub-2"    class="nav-main-link"   data-block-uuid="8abb77fe-5d11-4c0e-8136-5cc6dcf410f2" aria-expanded="false">
            <span>Events & <br/>Presentations</span>
          </a>
        
          
                
                                        
        


                                  <a href=""  aria-label="Stock Information"  class="nav-main-link" data-targetSubNav="nav-sub-3"    class="nav-main-link"   data-block-uuid="8abb77fe-5d11-4c0e-8136-5cc6dcf410f2" aria-expanded="false">
            <span>Stock <br/>Information</span>
          </a>
        
          
                
                                        
        


                                  <a href=""  aria-label="Financials"  class="nav-main-link" data-targetSubNav="nav-sub-4"    class="nav-main-link"   data-block-uuid="8abb77fe-5d11-4c0e-8136-5cc6dcf410f2" data-bs-toggle="dataToggle" aria-expanded="false">
            <span>Financials</span>
          </a>
        
          
                
                                        
        


                                  <a href=""  aria-label="Governance"  class="nav-main-link" data-targetSubNav="nav-sub-5"    class="nav-main-link"   data-block-uuid="8abb77fe-5d11-4c0e-8136-5cc6dcf410f2" data-bs-toggle="dataToggle" aria-expanded="false">
            <span>Governance</span>
          </a>
        
          
                
                                        
        


                                  <a href=""  aria-label="Resources"  class="nav-main-link" data-targetSubNav="nav-sub-6"    class="nav-main-link"   data-block-uuid="8abb77fe-5d11-4c0e-8136-5cc6dcf410f2" data-bs-toggle="dataToggle" aria-expanded="false">
            <span>Resources</span>
          </a>
        
          
                
              
    
  



    
    
                                
                                <div class="mobile-utility-links d-lg-none">
                                    <div class="mobile-nav-toggle">
                                        <img src="/sites/g/files/knoqqb100256/themes/site/client_site_301/local/images/icon/btn-nav-menu.svg" width="40" height="40"
                                             class="mobile-nav-toggle-icon" alt="open menu">
                                        <img src="/sites/g/files/knoqqb100256/themes/site/client_site_301/local/images/icon/btn-close-menu.svg" width="40" height="40"
                                             class="mobile-nav-toggle-icon nav-open" alt="close menu">
                                    </div>
                                </div>

                            </div><!-- END Nav Main -->
                        </div>
                    </nav>
                </div>
            </div>
        </div>

        <div class="row nav-subs-row" role="navigation" aria-label="Main Nav Sub Menus">
            <div class="nav-subs nav-subs-lvl-0 col-12 d-lg-none">
                <div class="nav-sub nav-sub-0">
                                            
    

              
              
                

    
    

                    
              
                  

        


          <a href="" aria-label="News"  class="subNavOpen"    data-targetSubNav="nav-sub-1"    class="subNavOpen" >
            <span>News</span>
          </a>

          

              

        


          <a href="" aria-label="Events &amp; Presentations"  class="subNavOpen"    data-targetSubNav="nav-sub-2"    class="subNavOpen" >
            <span>Events &amp; Presentations</span>
          </a>

          

              

        


          <a href="" aria-label="Stock Information"  class="subNavOpen"    data-targetSubNav="nav-sub-3"    class="subNavOpen" >
            <span>Stock Information</span>
          </a>

          

              

        


          <a href="" aria-label="Financials"  class="subNavOpen"    data-targetSubNav="nav-sub-4"    class="subNavOpen" >
            <span>Financials</span>
          </a>

          

              

        


          <a href="" aria-label="Governance"  class="subNavOpen"    data-targetSubNav="nav-sub-5"    class="subNavOpen" >
            <span>Governance</span>
          </a>

          

              

        


          <a href="" aria-label="Resources"  class="subNavOpen"    data-targetSubNav="nav-sub-6"    class="subNavOpen" >
            <span>Resources</span>
          </a>

          

              
    
  



    
    
                                    </div>
            </div>

            <div class="nav-subs nav-subs-lvl-1 col-12 col-lg-6 col-xl-5">

                                    
    

              
              
                

    
    

                    
              
                  
                          
        
        
        
                    <div class="nav-sub nav-sub-1">
              <button class="subNavClose" data-targetSubNav="nav-sub-1">Return to Top Level</button>
                                  
              
                  
                          
        
        
        
                  <a href="/news/press-releases"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5816" aria-label="Press Releases">
            <span>Press Releases</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/news/media-statements"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/13596" aria-label="Media Statements">
            <span>Media Statements</span>
          </a>
        
        

        
              
    
  
                          </div>
        
        

        
              
                          
        
        
        
                    <div class="nav-sub nav-sub-2">
              <button class="subNavClose" data-targetSubNav="nav-sub-2">Return to Top Level</button>
                                  
              
                  
                          
        
        
        
                  <a href="/events-and-presentations/events-and-recent"  class="subNavLink pageLink"     class="subNavLink pageLink" title="Upcoming &amp; Recent Events"  data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5821" aria-label="Upcoming &amp; Recent Events">
            <span>Upcoming &amp; Recent</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/events-and-presentations/archive"  class="subNavLink pageLink"     class="subNavLink pageLink" title="Archive Events"  data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/30291" aria-label="Archive Events">
            <span>Archive</span>
          </a>
        
        

        
              
    
  
                          </div>
        
        

        
              
                          
        
        
        
                    <div class="nav-sub nav-sub-3">
              <button class="subNavClose" data-targetSubNav="nav-sub-3">Return to Top Level</button>
                                  
              
                  
                          
        
        
        
                  <a href="/stock-information"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5916" aria-label="Stock Information">
            <span>Stock Information</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/stock-information/historic-stock-lookup"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5921" aria-label="Historic Price Lookup">
            <span>Historic Price Lookup</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/stock-information/investment-calculator"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5926" aria-label="Investment Calculator">
            <span>Investment Calculator</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/stock-information/ownership-profile"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5901" aria-label="Ownership Profile">
            <span>Ownership Profile</span>
          </a>
        
        

        
              
    
  
                          </div>
        
        

        
              
                          
        
        
        
                    <div class="nav-sub nav-sub-4">
              <button class="subNavClose" data-targetSubNav="nav-sub-4">Return to Top Level</button>
                                  
              
                  
                          
        
        
        
                  <a href="/financials/overview"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5871" aria-label="Financial Information">
            <span>Financial Information</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/financials/sec-filings"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5876" aria-label="SEC Filings">
            <span>SEC Filings</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/financials/annual-reports-and-proxy-statements"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5881" aria-label="Annual Reports &amp; Proxy Statements">
            <span>Annual Reports &amp; Proxy Statements</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/financials/quarterly-results"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5986" aria-label="Quarterly Results">
            <span>Quarterly Results</span>
          </a>
        
        

        
              
    
  
                          </div>
        
        

        
              
                          
        
        
        
                    <div class="nav-sub nav-sub-5">
              <button class="subNavClose" data-targetSubNav="nav-sub-5">Return to Top Level</button>
                                  
              
                  
                          
        
        
        
                  <a href="/governance/governance-documents"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5836" aria-label="Governance Documents">
            <span>Governance Documents</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="https://www.regeneron.com/responsibility"  class="subNavLink pageLink internalLink"     class="subNavLink pageLink internalLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" aria-label="Corporate Responsibility">
            <span>Corporate Responsibility</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/governance/committee-composition"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5851" aria-label="Committee Composition">
            <span>Committee Composition</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/governance/contact-the-board"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5866" aria-label="Contact the Board">
            <span>Contact the Board</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="/governance/insider-transactions"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/6106" aria-label="Insider Transactions">
            <span>Insider Transactions</span>
          </a>
        
        

        
              
    
  
                          </div>
        
        

        
              
                          
        
        
        
                    <div class="nav-sub nav-sub-6">
              <button class="subNavClose" data-targetSubNav="nav-sub-6">Return to Top Level</button>
                                  
              
                  
                          
        
        
        
                  <a href="/resources/investor-faqs"  class="subNavLink pageLink"     class="subNavLink pageLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" data-drupal-link-system-path="node/5941" aria-label="FAQs">
            <span>FAQs</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="https://www.regeneron.com/pipeline-medicines/investigational-pipeline"  class="subNavLink pageLink internalLink"  target="_blank"   class="subNavLink pageLink internalLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" aria-label="Pipeline">
            <span>Pipeline</span>
          </a>
        
        

        
              
                          
        
        
        
                  <a href="https://www.regeneron.com/pipeline-medicines/approved-medicines"  class="subNavLink pageLink internalLink"  target="_blank"   class="subNavLink pageLink internalLink"   data-block-uuid="b805bb3d-b161-4555-86bb-b7fc9dba2dcd" aria-label="Our Medicines">
            <span>Our Medicines</span>
          </a>
        
        

        
              
    
  
                          </div>
        
        

        
              
    
  



    
    
                
            </div>

                        <div class="utility-links d-lg-none" role="navigation">
                
    

              
              
                

    
    

                    
              
                  

        


          <a href="https://regeneron.com/" rel="nofollow noreferrer"  class="utility-link" target="_blank"   class="utility-link"  aria-label="Regeneron.com">Regeneron.com</a>

          

              

        


          <a href="https://www.regeneron.com/contact" rel="nofollow noreferrer"  class="utility-link contact-link"   target="_blank"   class="utility-link contact-link"  aria-label="Contact Us">Contact Us</a>

          

              


  


    
    


            </div>
            
        </div>
    </div>
</header>

<main id="mainContent" class="page-home">

    <section class="hero bkgd-white pb-0">
        <div class="hero-bkgd">
        </div>
        <div class="container">
            <div class="breadcrumbs" aria-label="Breadcrumb">
                                      <div class="region region-breadcrumbs">
    
<div id="block-client-site-301-breadcrumbs" class="block--system-breadcrumb-block block--system-breadcrumb-block--31106 block--breadcrumbs--system-breadcrumb-block block--breadcrumbs--system-breadcrumb-block--31106 block--8b003ad4-3813-471d-a550-9b872c8754e0 block--8b003ad4-3813-471d-a550-9b872c8754e0--31106 block block-system block-system-breadcrumb-block">
  
    
      
    

                    <span class="">
                <a href="https://investor.regeneron.com/news/press-releases">News</a>
            </span>
            <span> / </span>
            <span class="">
                <a href="https://investor.regeneron.com/news/press-releases">Press Releases</a>
            </span>

                    


    

                    
            
        


    

                    
                            <span> / </span>
                <span class="activePage" >
                Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization
            </span>
            
        


    

  </div>

  </div>

                
            </div>
            <div class="hero-content mb-0">


                                                                                                        <h1 class="hero-headline">
                        <span class="small-headline"></span>
                        <span>Release Details</span>
                    </h1>
                


            </div>
        </div>
    </section>

        <section>
        <div class="container">
            <div class="row">
                <div class="col-12">
                                                            <div >
                                                <div  class="lf-31106 cl-md-12" id="lfg-content">
                            
                              <div class="region region-content">
    <div id="block-client-site-301-websitenoticeblock" class="block--website-notice-block block--website-notice-block--31106 block--content--website-notice-block block--content--website-notice-block--31106 block--c0d61c8d-26f6-463a-9ef0-60a11d0d8f2b block--c0d61c8d-26f6-463a-9ef0-60a11d0d8f2b--31106 block block-nir-website-notices block-website-notice-block">
  
    
      
  </div>
<div data-drupal-messages-fallback class="hidden"></div>

<div id="block-client-site-301-content" class="block--system-main-block block--system-main-block--31106 block--content--system-main-block block--content--system-main-block--31106 block--9b4d8db0-6a4b-4bdb-bb0a-ccbf958c7fb6 block--9b4d8db0-6a4b-4bdb-bb0a-ccbf958c7fb6--31106 block block-system block-system-main-block">
  
    
      <article class="node node--nir-news--full node--type-nir-news node--view-mode-full node--promoted">

  <h2 class="h2">
<div class="field field--name-field-nir-news-title field--type-string field--label-hidden">
        <div class="field__item">Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization</div>
    </div>
</h2>
  <div class="llf-row llf-my-4 llf-align-items-top">
    <div class="llf-md-col llf-col-sm-6 llf-text-left">
<div class="field field--name-field-nir-news-date field--type-datetimezone field--label-hidden">
          <div class="field__item">June 24, 2025 at 7:30 AM EDT</div>

    </div>
</div>
    <div class="llf-md-col llf-col-sm-6 llf-text-sm-right llf-mt-3 llf-mt-sm-0 lf-pdf-version">

      
        <div class="file-link pdf-file-link">
  <span class="file file--mime-application-pdf file--application-pdf"><a href="/node/31106/pdf" type="application/pdf" target="_blank">PDF Version</a></span>
</div>
        
        
        

      
    </div>
  </div>
  <div class="node__content">
        <div class="full-release-body">
                    <center><b>Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medications</b></center>
<p><location value="LU/us.ny.tarown" idsrc="xmltag.org">TARRYTOWN, N.Y.</location>, <chron>June  24, 2025</chron>  (GLOBE NEWSWIRE) -- <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron Pharmaceuticals, Inc.</org> (NASDAQ: REGN) today announced the launch of a pioneering matching program for donations to Good Days, an independent national non-profit charitable organization, to support Good Days’ <org>Retinal Vascular and Neovascular Disease Fund</org>. Through this initiative, <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> has committed to matching donations up to a total of <money>$200 million</money> at a one-to-one rate for the remainder of the 2025 calendar year, enabling more patients to affordably access essential medicines that help protect their vision.</p>
<p>“We are proud to support Good Days with this unprecedented philanthropic effort,” said <person value="APIN:0966039374">Leonard Schleifer</person>, M.D., Ph.D., Board Co-Chair, President and Chief Executive Officer of <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org>. “By matching and thus doubling donations to Good Days’ <org>Retinal Vascular and Neovascular Disease Fund</org>, <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> can continue our longstanding support of patients through non-profit organizations, while encouraging others to join us in ensuring that even more patients can access the life-changing medicines they require to protect, restore and save their vision.”</p>
<p>The Fund offers copay assistance to <location value="LC/us" idsrc="xmltag.org">U.S.</location> patients who meet <a href="https://www.globenewswire.com/Tracker?data=w8D84071wIFDl-Y1aTEJjJhIa-v9SC_1dAC0rqzlle8cky5Y5k9eNdCXRtocVAuY57xLPy9whjJpShoH1HVkrA7_ve4O9MINU05ORmlZQtEiE-0MomRvxo45kqFd17rQ" rel="nofollow" target="_blank">certain criteria</a> as determined by Good Days. Donations are never intended to incentivize usage of any particular product, and this copay support is given without regard to what medicine patients are prescribed, as long as the medicine is FDA-approved to treat their covered diagnosis.</p>
<p>The donation matching program is part of <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org>'s broader commitment to improving patient outcomes and supporting healthcare access. <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> also facilitates access to medicines through product support and Managed Access Programs, patient assistance programs, and collaborations with experienced stakeholders, including nongovernmental organizations and public health agencies.</p>
<p><org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> remains committed to supporting patient access to medications and believes that patients should be able to access whatever therapy their physician prescribes for them. In the past decade, <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> has donated over <money>$2.5 billion dollars</money> to independent charitable organizations that provide financial support to patients.</p>
<p><org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> will match aggregated donations without receiving donor information; please contact Good Days directly to donate or for more information at: <a href="https://www.globenewswire.com/Tracker?data=ycF9YeVDZdktJPTRAd0IzCDyluVQ9y7T-HCzYvzkixSXb2xj6UhrzzMyJViDVFegtQBUYR17zpSIvB-3dzX1nX1ynuZVUMPt0PD6xziw9OPlPGE-VSRAgMMNnohy6jHC" rel="nofollow" target="_blank">donations@mygooddays.org</a>.</p>
<p><strong>About <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org>&nbsp;</strong><br><org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases.</p>
<p>Regeneron&nbsp;believes that operating as a good corporate citizen is crucial to delivering on our mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious disease, to foster a culture of integrity and excellence and to build sustainable communities.&nbsp;Regeneron&nbsp;is proud to be included on the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the&nbsp;U.S.&nbsp;Throughout the year,&nbsp;Regeneron&nbsp;empowers and supports employees to give back through our volunteering, pro-bono and matching gift programs. Our most significant philanthropic commitments are in the area of science education, including the&nbsp;<a href="https://www.globenewswire.com/Tracker?data=dvgCTjQpZqW7QoUGpfchioBE4ePKjvgDBiusYGlCyl9aljwUrdNnYIHmU_mgRqqxZc6gsmwVz_tlP1wCqJ9ctYb5kemeMo62ScuThOU56KT_wFxAcqAjpPlQs_O4brffN1VdxpZWW4VccUIobMIV5hduHBraPgtexqcUTO7GatrK1qrfowSQD6rrW74WVRjwS6oHR9ThaL-DaNUINY94C8Mm0iZTWI3rPNp9N4ggCDVJjxJ9K-Xv1t_t3IRIeMApug0_NSs1pzKgh8LGATIdl37SwL7zHxYBY24dNKqkYOrBmKn6WUf8mnSp8Z_j1_sBbuXdmKO8dgQADuL7wyEHgw==" rel="nofollow" target="_blank">Regeneron&nbsp;Science Talent Search</a>&nbsp;and the&nbsp;<a href="https://www.globenewswire.com/Tracker?data=dvgCTjQpZqW7QoUGpfchivdChwMGBEz7A7wIummeKol5tA44Ho6pdUtx0BX30DI-fWg26RDkB8H5vyifvwDcnJL4SSZWia1wXKE8SVMmQ37DHdo2Sa6MWnuqxsSp32_ZC9GDIYVXGNo0p0R2N59jogjuGNxvkCDPs7zw4Wg7SCJ2LZHTC02Qq4Bv5UYB-7MXovg32P150Sq-ocJNC85CCmjAklb-XZ1-0heX6Q2LK7LW-cZnxdrenfb8V8HADcRn50GWBmQkypkXkfCSjnx28y-NFsriKjGomYDu50PvwsrzrFNHOrE7hymLksCjDKYNBOf10brp4OYXrOCt4a4rwPB4RiqJ_FN_mnVpQEXo3-lhMnUIKVlapwqst7ZtaQCHTenSm31EkoovjLFzLH_pcQ==" rel="nofollow" target="_blank">Regeneron&nbsp;International Science and Engineering Fair (ISEF)</a>.</p>
<p>For more information, please visit&nbsp;<a href="https://www.globenewswire.com/Tracker?data=QzSuq_wh9gTNgb8uDOerkMGde75-x_IINTRiPdqNMGAnoTFrx4AygUfEwwCKsu0NdLUrmp-vqEPRcSWgTs2l_qNyavUcbOZ7mWrPNdWm4hQ=" rel="nofollow" target="_blank">www.Regeneron.com</a>&nbsp;or follow <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> on&nbsp;<a href="https://www.globenewswire.com/Tracker?data=zelhcU9DMjS6mbGOse-LidZtxzOs_2i9xXBNs-UIe8mF6itqvAHqIlCECglLsRpLsDZ6Oq-QaEND8XnBlg_9v4G2xbI7dDyOSzhNfNlm7yGjBPsXYt0Yl08C1H7ZIp5pLwhN8Hg_qTbWale_MJOm_teagQo2ga-692gITQUCOGs=" rel="nofollow" target="_blank">LinkedIn</a>,&nbsp;<a href="https://www.globenewswire.com/Tracker?data=syuZgTeFPDXD8-lFkUq5AKGcfNiaSIaEifhA0Pzg2Nx4aLcjklTPqyuLLD_Pbmr7-KN7TKw7IZbaP43Bee5nBTolLWE1pYk7tQW022vIYS9A0BfzBWpnaEPDQLaYsxBpYSuwVitHUQZekYOxp0HquxpQu-S82sq4g98cp6HGfIj1-Gl01rZFvIRgZSOatTPF4adLqy4-AjEgtHonpKayrPQ_IUgAcZS-lcGlAhFloR45CINrjCUA27kL48Clep52" rel="nofollow" target="_blank">Instagram</a>,&nbsp;<a href="https://www.globenewswire.com/Tracker?data=HEisyp0SMv9KAr6d6nMPWeJkmf20jMaBYZpjiIrReHxnti7rmovzvR27Phh1taLEc8TrD1lL_YoqALTpF8QCZT9HkLd2Xb-rZM2rut1I0zm1asGH-TvxJioFLrVlwfWsLR44qvHHibjsqI7jHIp1CHJzNzOaZqzS3khMjj3G3aQel2ak-0_S4wjekXbp_kubVHSuk9gR-ONS3eNjnBVOu9fh5kgHZHjm98BMBofi8r90FpIaV90NkCI0hHXAHYWM" rel="nofollow" target="_blank">Facebook</a>&nbsp;or&nbsp;<a href="https://www.globenewswire.com/Tracker?data=O2bwth0xF8acLpYU-pj-xVXg733wHMEQ1FujrxFq3NOxMYvYksjpm6KtGDy6mNRFI63LClP03F4xYBxJ19Or-oB_xLuNnBHA8cxeFSyzKd99TEatXg-dIHPaRZt_v3_Vtqwww_XcPm5CDAvKXGArXqyKmHELB-ebb9tgSDwQ81c_UhLkeYKyTmH3PKEBH17iIqz4FtWGnyzZ8tBFxUGzsA==" rel="nofollow" target="_blank">X</a>.</p>
<p><strong>Forward-Looking Statements and Use of Digital Media</strong><br><em>This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron Pharmaceuticals, Inc.</org> (“Regeneron” or the “Company”), and actual events or results may differ materially from these forward-looking statements. Words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “seek,” “estimate,” variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. These statements concern, and these risks and uncertainties include, among others, the availability and extent of reimbursement or copay assistance for products marketed or otherwise commercialized by <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> and/or its collaborators or licensees (collectively, “Regeneron’s Products”) from third-party payors and other third parties, including Good Days and Good Days’ <org>Retinal Vascular and Neovascular Disease Fund</org> as discussed in this press release, as well as private payor healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payors and other third parties and new policies and procedures adopted by such payors and other third parties, including the matching program for donations to Good Days to support Good Days’ <org>Retinal Vascular and Neovascular Disease Fund</org> as discussed in this press release; changes in laws, regulations, and policies affecting the healthcare industry; competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron’s Products and product candidates being developed by <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> and/or its collaborators or licensees (collectively, “Regeneron’s Product Candidates”) (including biosimilar versions of Regeneron’s Products);&nbsp;the nature, timing, and possible success and therapeutic applications of Regeneron’s Products and Regeneron’s Product Candidates and research and clinical programs now underway or planned</em><em>; uncertainty of the utilization, market acceptance</em><em>, and commercial success of Regeneron’s Products and Regeneron’s Product Candidates and the impact of studies (whether conducted by <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> or others and whether mandated or voluntary) on any of the foregoing; the likelihood, timing, and scope of possible regulatory approval and commercial launch of Regeneron’s Product Candidates and new indications for Regeneron’s Products; the ability of Regeneron’s collaborators, licensees, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling, distribution, and other steps related to Regeneron’s Products and Regeneron’s Product Candidates; the ability of <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> to manage supply chains for multiple products and product candidates and risks associated with tariffs and other trade restrictions; safety issues resulting from the administration of Regeneron’s Products and Regeneron’s Product Candidates in patients, including serious complications or side effects in connection with the use of Regeneron’s Products and Regeneron’s Product Candidates in clinical trials; the extent to which the results from the research and development programs conducted by <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> and/or its collaborators or licensees may be replicated and/or lead to advancement of product candidates to clinical trials, therapeutic applications, or regulatory approval; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron’s ability to continue to develop or commercialize Regeneron’s Products and Regeneron’s Product Candidates; ongoing regulatory obligations and oversight impacting Regeneron’s Products, research and clinical programs, and business, including those relating to patient privacy; unanticipated expenses; the costs of developing, producing, and selling products; the ability of <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> to meet any of its financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license, collaboration, or supply agreement, including Regeneron’s agreements with Sanofi and Bayer (or their respective affiliated companies, as applicable), to be cancelled or terminated; the impact of public health outbreaks, epidemics, or pandemics on <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org>'s business; and risks associated with litigation and other proceedings and government investigations relating to the Company and/or its operations (including the pending civil proceedings initiated or joined by the <org value="ACORN:0746094848" idsrc="xmltag.org">U.S. Department of Justice</org> and the <org>U.S. Attorney's Office for the District of Massachusetts</org>), risks associated with intellectual property of other parties and pending or future litigation relating thereto (including without limitation the patent litigation and other related proceedings relating to EYLEA</em><sup><em>®</em></sup><em> (aflibercept) Injection), the ultimate outcome of any such proceedings and investigations, and the impact any of the foregoing may have on Regeneron’s business, prospects, operating results, and financial condition. A more complete description of these and other material risks can be found in Regeneron’s filings with the <org value="ACORN:0964256832" idsrc="xmltag.org">U.S. Securities and Exchange Commission</org>, including its Form 10-K for the year ended <chron>December 31, 2024</chron>, and its Form 10-Q for the quarterly period ended <chron>March 31, 2025</chron>. Any forward-looking statements are made based on management’s current beliefs and judgment, and the reader is cautioned not to rely on any forward-looking statements made by <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org>. <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> does not undertake any obligation to update (publicly or otherwise) any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise.</em></p>
<p><em><org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> uses its media and investor relations website and social media outlets to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org> is routinely posted and is accessible on <org value="NASDAQ-NMS:REGN" idsrc="xmltag.org">Regeneron</org>'s media and investor relations website (<a href="https://investor.regeneron.com">https://investor.regeneron.com</a>) and its LinkedIn page (<a href="https://www.linkedin.com/company/regeneron-pharmaceuticals">https://www.linkedin.com/company/regeneron-pharmaceuticals</a>).</em></p>
<table style="border-collapse: collapse; width:100%; border-collapse:collapse ;">
  <tr>
    <td style="max-width:50%; width:50%; min-width:50%;;vertical-align: top ; "><strong>Contacts:</strong><br><br><strong>Media Relations</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br><a href="mailto:media@regeneron.com" rel="nofollow" target="_blank">media@regeneron.com</a><br></td>
    <td style="max-width:50%; width:50%; min-width:50%;;vertical-align: top ; "><br><br><strong>Investor Relations</strong><br><a href="mailto:invest@regeneron.com" rel="nofollow" target="_blank">invest@regeneron.com</a><br></td>
  </tr>
</table><img alt class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTQ4MzI0NyM3MDE0NTg4IzIwMDYyNTA="><br><img alt src="https://ml.globenewswire.com/media/MWRjODgxZGEtMjAwMC00YzIyLTkxOGQtZmE5YTAwOTE0OWIwLTEwMTc4MjMtMjAyNS0wNi0yNC1lbg==/tiny/Regeneron-Pharmaceuticals-Inc-.png" referrerpolicy="no-referrer-when-downgrade"><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/add5ebc7-88c9-49dc-8834-abbb07c622d1"><img src="https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg" border="0" width="150" height="24" alt="Primary Logo" loading="lazy"></a></p>
<p>
Source: Regeneron Pharmaceuticals, Inc.</p>
  
          </div>
  </div>

</article>

  </div>

  </div>

                        </div>
                    </div>

                </div>
            </div>
        </div>
    </section>
    


    

    
</main>

<div class="container back-to-top-container">
    <a href="#" class="btn-back-to-top hideThis" title="Click to Scroll back to top" role="button"><span>Back to top</span></a>
</div>

<footer>
    <div class="container">
        <div class="row">
            <div class="col-12 col-lg-3 mb-4 logoLinks">
                <a href="/" target="_blank" rel="nofollow noreferrer" class="link-img d-inline-block" aria-label="Go to Regeneron Pharmaceuticals Inc. Homepage">
                    <img src="/sites/g/files/knoqqb100256/themes/site/client_site_301/local/images/logo/logo-regeneron-footer.svg" width="246" height="49" alt="Regeneron: Science to Medigine Logo." />
                </a>
                                    <div class="socialLinks mx-0" role="navigation" aria-label="social media">
                         
    

              
              
                

    
    

                


    
                    

      <a href="https://www.linkedin.com/company/regeneron-pharmaceuticals" rel="external"  class="externalLink"  target="_blank"  data-bs-toggle="modal" data-bs-target="#modal-wol-external" aria-label="Visit Regeneron’s LinkedIn page">
        <img src="/sites/g/files/knoqqb100256/themes/site/client_site_301/local/images/logo/logo-linkedin-dark.svg" width="20" height="20" title="Visit Regeneron’s LinkedIn page" alt="LinkedIn logo.">
      </a>
    
                    

      <a href="https://www.instagram.com/regeneron/" rel="external"  class="externalLink"  target="_blank"  data-bs-toggle="modal" data-bs-target="#modal-wol-external" aria-label="Visit Regeneron’s Instagram page">
        <img src="/sites/g/files/knoqqb100256/themes/site/client_site_301/local/images/logo/logo-instagram-dark.svg" width="20" height="20" title="Visit Regeneron’s Instagram page" alt="Instagram logo.">
      </a>
    
                    

      <a href="https://www.facebook.com/Regeneron" rel="external"  class="externalLink"  target="_blank"  data-bs-toggle="modal" data-bs-target="#modal-wol-external" aria-label="Visit Regeneron’s Facebook page">
        <img src="/sites/g/files/knoqqb100256/themes/site/client_site_301/local/images/logo/logo-facebook-dark.svg" width="20" height="20" title="Visit Regeneron’s Facebook page" alt="Facebook logo.">
      </a>
    
                    

      <a href="https://www.youtube.com/c/Regeneron/" rel="external"  class="externalLink"  target="_blank"  data-bs-toggle="modal" data-bs-target="#modal-wol-external" aria-label="Visit Regeneron’s YouTube channel">
        <img src="/sites/g/files/knoqqb100256/themes/site/client_site_301/local/images/logo/logo-youtube-dark.svg" width="20" height="20" title="Visit Regeneron’s YouTube channel" alt="YouTube logo.">
      </a>
    
      

      <a href="https://twitter.com/regeneron" rel="external"  class="externalLink"  target="_blank"  data-bs-toggle="modal" data-bs-target="#modal-wol-external" aria-label="Visit Regeneron’s X page">
        <img src="/sites/g/files/knoqqb100256/themes/site/client_site_301/local/images/logo/logo-x-dark.svg" width="20" height="20" title="Visit Regeneron’s X page" alt="X logo.">
      </a>
    



    
    
                    </div>
                            </div>

            <div class="col-12 col-lg-9" role="navigation" aria-label="footer">
                                    
    

              
              
<div class="row utilityLinks justify-content-start" role="list">
                

    
    

                    
              
                  

        

        <div class="col-12 col-lg-3 mb-2" role="listitem">

          <a href="https://www.regeneron.com/contact" rel="nofollow noreferrer" aria-label="Contact Us"  class="link-caret"    class="link-caret" >
            <span>Contact Us</span>
          </a>

        </div>

          

              

        

        <div class="col-12 col-lg-3 mb-2" role="listitem">

          <a href="https://www.regeneron.com/" rel="nofollow noreferrer" aria-label="Regeneron.com"  class="link-caret"    class="link-caret" >
            <span>Regeneron.com</span>
          </a>

        </div>

          

              

        

        <div class="col-12 col-lg-3 mb-2" role="listitem">

          <a href="https://careers.regeneron.com/" rel="nofollow noreferrer" aria-label="Careers"  class="link-caret internalLink" target="_blank"   class="link-caret internalLink" >
            <span>Careers</span>
          </a>

        </div>

          

              

        

        <div class="col-12 col-lg-3 mb-2" role="listitem">

          <a href="https://clinicaltrials.regeneron.com/" rel="nofollow noreferrer" aria-label="Clinical Trials"  class="link-caret internalLink" target="_blank"   class="link-caret internalLink" >
            <span>Clinical Trials</span>
          </a>

        </div>

          

              


  



    
  </div>
  
                                                <div class="row otherLinks mb-3" >
                     
    

              
              
                

    
    

                    
                  
      

        
        
                          <div class="col-5 col-lg-12" >
                <div class="row" role="list">
                                          
                  
      

        
                  <div class="col-12  mb-2" role="listitem">
            <a href="https://www.regeneron.com/terms" aria-label="Terms of Use"  rel="nofollow noreferrer"   class="link-utility"    class="link-utility" >
              <span>Terms of Use</span>
            </a>
          </div>
        

              

        
                  <div class="col-12  mb-2" role="listitem">
            <a href="https://www.regeneron.com/accessibility-statement" aria-label="Accessibility Statement"  rel="nofollow noreferrer"   class="link-utility"    class="link-utility" >
              <span>Accessibility Statement</span>
            </a>
          </div>
        

              

        
                  <div class="col-12  mb-2" role="listitem">
            <a href="/static-files/fe3ba074-f94a-41f3-9630-51f4da21e950" aria-label="Cookie Policy"  rel="nofollow noreferrer"   class="link-utility" target="_blank"   class="link-utility" >
              <span>Cookie Policy</span>
            </a>
          </div>
        

              

        
                  <div class="col-12  mb-2" role="listitem">
            <a href="/sitemap" aria-label="Site Map"  rel="nofollow noreferrer"   class="link-utility"    class="link-utility" >
              <span>Site Map</span>
            </a>
          </div>
        

              
  
                                  </div>
              </div>
                    

              

        
        
                          <div class="col-7 col-lg-12" >
                <div class="row" role="list">
                                          
                  
      

        
                  <div class="col-12  mb-2" role="listitem">
            <a href="https://www.regeneron.com/social-media-terms" aria-label="Social Media Terms"  rel="nofollow noreferrer"   class="link-utility"    class="link-utility" >
              <span>Social Media Terms</span>
            </a>
          </div>
        

              

        
                  <div class="col-12  mb-2" role="listitem">
            <a href="https://www.regeneron.com/privacy-notice" aria-label="Privacy Notice"  rel="nofollow noreferrer"   class="link-utility"    class="link-utility" >
              <span>Privacy Notice</span>
            </a>
          </div>
        

              

        
                  <div class="col-12  mb-2" role="listitem">
            <a href="#/" aria-label="Privacy Preference Center" id="ot-sdk-btn" rel="nofollow noreferrer"   class="link-utility ot-sdk-show-settings"    class="link-utility ot-sdk-show-settings" >
              <span>Privacy Preference Center</span>
            </a>
          </div>
        

              
  
                                  </div>
              </div>
                    

              
  




    
    
                </div>
                
                <div class="row">
                    <div class="col-12 mb-4 pt-lg-0 copyLine">
                        <p class="mb-0">Copyright &copy; 2025 Regeneron Pharmaceuticals Inc.. All rights reserved. All trademarks
                        mentioned are the property of their respective owners.</p>
                    </div>
                </div>
            </div>
        </div>
    </div>
</footer>
<div class="ndm-modal fade" id="leave-regeneron-modal" aria-hidden="true" tabindex="-1">
    <div class="ndm-modal-dialog ndm-modal-dialog-centered ndm-modal-lgWidth" id="modal-lgWidth" role="document" data-bg-theme="dark">
        <div class="ndm-modal-wol ndm-modal-content ndm-modal-success">
            <button type="button" class="close ndm-modal-close-btn" data-bs-dismiss="modal" aria-label="Close">Close</button>
            <p>
                You are now leaving Investor.Regeneron.com. The site you are about to visit is maintained by a third
                party who is solely responsible for its content. We encourage you to read the privacy policy of every
                website you visit.
            </p>
            <div>
                <div class="d-md-flex align-items-center">
                    <div class="mt-3">
                        <a class="btn btn-primary download leave-regeneron-yes" href="" target="_blank" role="button" aria-label="Press to continue">
                            <div class="btn-content">
                                <span>Continue</span>
                            </div>
                        </a>
                    </div>

                    <button type="button" class="close btn btn-secondary ms-md-3" data-bs-dismiss="modal" aria-label="Press to Close">
                        <div class="btn-content">
                            <span>Return to Investor.Regeneron.com</span>
                        </div>
                    </button>
                </div>
            </div>
        </div>
    </div>
</div>
<div class="ndm-modal fade" id="leave-regeneron-modal-to-regeneron" aria-hidden="true" tabindex="-1">
    <div class="ndm-modal-dialog ndm-modal-dialog-centered ndm-modal-lgWidth" id="modal-lgWidth" role="document" data-bg-theme="dark">
        <div class="ndm-modal-wol ndm-modal-content ndm-modal-success">
            <button type="button" class="close ndm-modal-close-btn" data-bs-dismiss="modal" aria-label="Close">Close</button>
            <p>
                You are now leaving Investor.Regeneron.com to visit another Regeneron website.
            </p>
            <div>
                <div class="d-md-flex align-items-center">
                    <div class="mt-3">
                        <a class="btn btn-primary download leave-regeneron-yes" href="" target="_blank" role="button" aria-label="Press to continue">
                            <div class="btn-content">
                                <span>Continue</span>
                            </div>
                        </a>
                    </div>

                    <button type="button" class="close btn btn-secondary ms-md-3" data-bs-dismiss="modal" aria-label="Press to Close">
                        <div class="btn-content">
                            <span>Return to Investor.Regeneron.com</span>
                        </div>
                    </button>
                </div>
            </div>
        </div>
    </div>
</div>
<div class="ndm-modal fade" id="leave-regeneron-modal-global-site" aria-hidden="true" tabindex="-1">
    <div class="ndm-modal-dialog ndm-modal-dialog-centered ndm-modal-lgWidth" id="modal-lgWidth" role="document" data-bg-theme="dark">
        <div class="ndm-modal-wol ndm-modal-content ndm-modal-success">
            <button type="button" class="close ndm-modal-close-btn" data-bs-dismiss="modal" aria-label="Close">Close</button>
            <p>
                You are now leaving Investor.Regeneron.com. The site you are about to visit is maintained by a third
                party who is solely responsible for its content. We encourage you to read the privacy policy of every
                website you visit.
            </p>
            <div>
                <div class="d-md-flex align-items-center">
                    <div class="mt-3">
                        <a class="btn btn-primary download leave-regeneron-yes" href="" target="_blank" role="button" aria-label="Press to Continue">
                            <div class="btn-content">
                                <span>Continue</span>
                            </div>
                        </a>
                    </div>

                    <button type="button" class="close btn btn-secondary ms-md-3" data-bs-dismiss="modal" aria-label="Press to Close">
                        <div class="btn-content">
                            <span>Return to Investor.Regeneron.com</span>
                        </div>
                    </button>
                </div>
            </div>
        </div>
    </div>
</div>
<div class="ndm-modal fade" id="leave-regeneron-modal-global-site-to-regeneron" aria-hidden="true" tabindex="-1">
    <div class="ndm-modal-dialog modal-dialog-centered ndm-modal-lgWidth" id="modal-lgWidth" role="document" data-bg-theme="dark">
        <div class="ndm-modal-wol ndm-modal-content ndm-modal-success">
            <button type="button" class="close ndm-modal-close-btn" data-bs-dismiss="modal" aria-label="Close">Close</button>
            <p>
                You are now leaving Investor.Regeneron.com to visit another Regeneron website.
            </p>
            <div>
                <div class="d-md-flex align-items-center">
                    <div class="mt-3">
                        <a class="btn btn-primary download leave-regeneron-yes" href="" target="_blank" role="button" aria-label="Press to Continue">
                            <div class="btn-content">
                                <span>Continue</span>
                            </div>
                        </a>
                    </div>
                    <button type="button" class="close btn btn-secondary ms-md-3" data-bs-dismiss="modal" aria-label="Press to Close">
                        <div class="btn-content">
                            <span>Return to Investor.Regeneron.com</span>
                        </div>
                    </button>
                </div>
            </div>
        </div>
    </div>
</div>

  </div>

    
          <script type="text/javascript">var s_CCSWebHostingAccount = "trcgregeneronpharmaceuticals";</script>
        <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/31106","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","themeUrl":"sites\/g\/files\/knoqqb100256\/themes\/site\/client_site_301"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"eJyNkVtqAzEMRTcUxildkJBtkThjS0FSmnb3dTSFZgqF4A9L14erh0tvxA7WnOD9-Jbkg_SuM7MDNwVk7F_eiqVdtmCVTNDxxuX8AnhVqYFlNAqiFWHbSy7SM2qIZaXaXBQq-jy5k6XfMJCBupIHALlLWVNUNQdFb3yaxtPnjOov4Qbh_Q87CBmUioxBPPUm_Ox9697G7BjTPo3XK562AR_Bghf8BKwVSkczwE7q20B3yvENLHNztC3yj7b83AebjdNIj919A7DOsns","theme":"client_site_301","theme_token":null},"ajaxTrustedUrl":[],"nir_admin_use_chosen":false,"nir_admin_use_select2":false,"chairtextvars":{"chairpersontext":"Chair","chairtext":"Chair"},"lfg_accordions":{"no_functionality":1,"speed":"fast","show_text":"Show All","hide_text":"Hide All","show_all":0},"lfg_chosen":{"enabled":1,"blank_text":"Choose from list","disable_search":1,"disable_search_threshold":10},"membertextvars":{"memberpersontext":"Member"},"user":{"uid":0,"permissionsHash":"1a7e8b3bf279d83172b475ab498aa2d4b25c6cd5f13282974906a6416878efc1"}}</script>
<script src="https://code.jquery.com/jquery-3.7.1.min.js"></script>
<script src="/sites/g/files/knoqqb100256/files/js/js_uF9E76OU-sq77srtPIUtRiYLXzbvGEAGp24c0ejRZtA.js?scope=footer&amp;delta=1&amp;language=en&amp;theme=client_site_301&amp;include=eJyNj9EOwjAIRX_ItBo_iLBClMnahTKnf2_Tacx8MjxwL5yQS1Lh7FDFGc7HUyx3ttWaq4csBphRny6pxp0LSGVgUFxyuv4BzlaoY-nGJF4MCL3VoFzjV3ZkWtRlahjGve3bGS8cPyLgiA9AIkiKtQIqm29XVh76T7m0GLyl-pmFd38B1u1mog"></script>
<script src="https://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js" crossorigin="anonymous" async integrity="sha384-9QSqHMB+yiy/V4i+d2Au+ydEWbBz4E9DqsE+oYKOnL+kj4XAZGYZxabd0P3OGHkf"></script>
<script src="/core/assets/vendor/ckeditor5/ckeditor5-dll/ckeditor5-dll.js?v=44.0.0"></script>
<script src="/profiles/nasdaqir/modules/custom/nir_ckeditor_datatables/js/build/datatables.js?v=1.10.9"></script>
<script src="/sites/g/files/knoqqb100256/files/js/js_TmP0eCxP9HtMHruUKlwYFfqzKMkWk-ji83WiVxqwbBE.js?scope=footer&amp;delta=5&amp;language=en&amp;theme=client_site_301&amp;include=eJyNj9EOwjAIRX_ItBo_iLBClMnahTKnf2_Tacx8MjxwL5yQS1Lh7FDFGc7HUyx3ttWaq4csBphRny6pxp0LSGVgUFxyuv4BzlaoY-nGJF4MCL3VoFzjV3ZkWtRlahjGve3bGS8cPyLgiA9AIkiKtQIqm29XVh76T7m0GLyl-pmFd38B1u1mog"></script>

    <!-- Google Tag Manager (noscript) -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N94H6NR3"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->

  </body>
</html>
